Table 2.
Baseline clinical characteristics of CRSwNP patients among two groups.
| Variables | Non-MetS (n = 398) | MetS (n = 157) | p |
|---|---|---|---|
| Age, years | 42.7 (30.0–54.0) | 52.1 (46.0–63.0) | <0.001 |
| Male, n (%) | 265 (66.5) | 100 (63.7) | 0.552 |
| Smoking, n (%) | 51 (12.9) | 39 (24.6) | 0.001 |
| Alcohol consumption, n (%) | 23 (5.8) | 22 (14.0) | 0.003 |
| Duration of disease, months | 63.1 (12.0–84.0) | 88.0 (7.0–120.0) | 0.417 |
| Allergic rhinitis, n (%) | 104 (26.1) | 45 (28.7) | 0.595 |
| Asthma, n (%) | 29 (7.3) | 11 (7.0) | 1.000 |
| BMI, kg/m2 | 23.6 (21.2–25.5) | 27.5 (25.5–28.7) | <0.001 |
| FBG, mmoL/L | 5.0 (4.6–5.3) | 6.4 (4.9–7.4) | <0.001 |
| SBP, mmHg | 123.8 (113.0–132.0) | 144.1 (130.0–159.0) | <0.001 |
| DBP, mmHg | 78.3 (72.0–84.0) | 89.8 (79.5–100.0) | <0.001 |
| TC, mmoL/L | 4.8 (4.2–5.4) | 4.8 (4.1–5.5) | 0.858 |
| LDL-C, mmoL/L | 2.9 (2.5–3.3) | 3.2 (2.7–3.7) | 0.002 |
| TG, mmoL/L | 1.5 (1.0–1.7) | 2.7 (1.8–3.1) | <0.001 |
| HDL-C, mmoL/L | 1.2 (1.0–1.3) | 1.0 (0.8–1.1) | <0.001 |
| MetS component | |||
| Overweight or obesity, n (%) | 57 (14.3) | 93 (59.2) | <0.001 |
| Hypertension, n (%) | 57 (14.3) | 99 (63.1) | <0.001 |
| Hyperglycemia, n (%) | 42 (10.6) | 116 (73.9) | <0.001 |
| Dyslipidemia, n (%) | 76 (19.1) | 114 (72.6) | <0.001 |
| Recurrent CRSwNP, n (%) | <0.001 | ||
| Yes | 146 (36.7) | 86 (54.8) | |
| No | 252 (63.3) | 71 (45.2) | |
CRSwNP, Chronic Rhinosinusitis With Nasal Polyps; MetS, Metabolic Syndrome; BMI, Body Mass Index; FBG, Fasting Blood Glucose; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; TG, Triglyceride; HDL-C, High Density Lipoprotein-Cholesterol.